Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine hydrochloride anhydrous + povidone-iodine + sodium
- Development stage
- Unknown
- Lead developer
- AstraZeneca
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
A topical combination product containing **lidocaine hydrochloride anhydrous**, a local anesthetic that reduces pain by reversibly blocking voltage-gated sodium channels in peripheral nerves, and **povidone-iodine**, a broad-spectrum iodophor antiseptic that releases free iodine and kills microorganisms through iodination and oxidation of cellular components. The trailing term **sodium** appears to refer to an incompletely specified sodium-containing component or excipient rather than a clearly identified active pharmaceutical ingredient in the queried name, so the exact marketed product cannot be assigned with confidence. Overall, the name most plausibly refers to a first-aid topical antiseptic and anesthetic combination intended for minor cuts, scrapes, burns, or skin preparation, but the formulation as written is not a standard fully specific drug name.
- Other names
- lidocaine hydrochloride anhydrous + povidone-iodine + sodium
02
Targets
NaV (Voltage-gated sodium channels)Microbial membrane lipids and fatty acids
Beyond the preview
Go deeper on lidocaine hydrochloride anhydrous + povidone-iodine + sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lidocaine hydrochloride anhydrous + povidone-iodine + sodium.